ZERVIATE Drug Patent Profile
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
When do Zerviate patents expire, and what generic alternatives are available?
Zerviate is a drug marketed by Eyevance and is included in one NDA. There are four patents protecting this drug.
This drug has twenty-three patent family members in seven countries.
The generic ingredient in ZERVIATE is cetirizine hydrochloride. There are thirty-nine drug master file entries for this compound. One hundred and fifty-six suppliers are listed for this compound. Additional details are available on the cetirizine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Zerviate
A generic version of ZERVIATE was approved as cetirizine hydrochloride by TEVA PHARMS on May 27th, 2008.
Summary for ZERVIATE
International Patents: | 23 |
US Patents: | 4 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 118 |
Patent Applications: | 3,181 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for ZERVIATE |
What excipients (inactive ingredients) are in ZERVIATE? | ZERVIATE excipients list |
DailyMed Link: | ZERVIATE at DailyMed |


Pharmacology for ZERVIATE
Drug Class | Histamine-1 Receptor Antagonist |
Mechanism of Action | Histamine H1 Receptor Antagonists |
Anatomical Therapeutic Chemical (ATC) Classes for ZERVIATE
US Patents and Regulatory Information for ZERVIATE
ZERVIATE is protected by four US patents.
Patents protecting ZERVIATE
Ophthalmic formulations of cetirizine and methods of use
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Ophthalmic formulations of cetirizine and methods of use
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Ophthalmic formulations of cetirizine and methods of use
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Ophthalmic formulations of cetirizine and methods of use
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: TREATMENT OF OCULAR ITCHING ASSOCIATED WITH ALLERGIC CONJUNCTIVITIS
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Eyevance | ZERVIATE | cetirizine hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 208694-001 | May 30, 2017 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Eyevance | ZERVIATE | cetirizine hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 208694-001 | May 30, 2017 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Eyevance | ZERVIATE | cetirizine hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 208694-001 | May 30, 2017 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Eyevance | ZERVIATE | cetirizine hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 208694-001 | May 30, 2017 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for ZERVIATE
See the table below for patents covering ZERVIATE around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Mexico | 2011009802 | FORMULACIONES OFTALMICAS DE CETIRIZINA Y METODOS DE USO. (OPHTHALMIC FORMULATIONS OF CETIRIZINE AND METHODS OF USE.) | ⤷ Try a Trial |
Japan | 6033677 | ⤷ Try a Trial | |
Spain | 2910374 | ⤷ Try a Trial | |
Portugal | 2408453 | ⤷ Try a Trial | |
Japan | 2018141022 | セチリジンの眼科用製剤および使用方法 (OPHTHALMOLOGIC PREPARATION OF CETIRIZINE AND METHODS OF USE) | ⤷ Try a Trial |
Japan | 2015007136 | セチリジンの眼科用製剤および使用方法 (OPHTHALMIC FORMULATIONS OF CETIRIZINE AND METHODS OF USE) | ⤷ Try a Trial |
Canada | 2755679 | FORMULATIONS OPHTALMIQUES DE CETIRIZINE ET PROCEDES D'UTILISATION (OPHTHALMIC FORMULATIONS OF CETIRIZINE AND METHODS OF USE) | ⤷ Try a Trial |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for ZERVIATE
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0058146 | 2001C/045 | Belgium | ⤷ Try a Trial | PRODUCT NAME: DICHLORHYDRATE DE LEVOCETIRIZINE; NAT RER. NO/DATE: 194 IS 90 F3 20011022; FIRST REG.: DE 49903.00.00 20010103 |
0663828 | C300085 | Netherlands | ⤷ Try a Trial | PRODUCT NAME: LEVOCETIRIZINE, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT, IN HET BIJZONDER LEVOCETIRINE DIHYDROCHLORIDE; NAT. REGISTRATION NO/DATE: RVG 26770 20011009; FIRST REGISTRATION: DE 49903.00.00 AND 49904.00.00 20010103 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |